Tuesday, June 16, 2026

Tesla Stock Jumps to $400 After China Sales Surge 91%

Tesla's stock rose 2.15% after a 91% increase in China sales, contrasting with the struggling local EV market.

Saving Poverty vs Free Trade Society? How Celltrion’s Biosimilar Could Reshape the U.S. Healthcare Market

Professor Metz highlights biosimilars' potential to expand patient access to treatments, emphasizing Omliclo's impact at EADV conference.

North Korea Condemns Upcoming U.S.–South Korea Joint Exercise

North Korea condemns the upcoming U.S.-South Korea joint exercise and emphasizes self-reliance and anti-Japanese sentiment ahead of Liberation Day.

Kyo Woon Koo

Author's Latest

South Korean Team Develops Non-Invasive Device for Early Cardiovascular Risk Screening

South Korean researchers developed the Coronyzer, a non-invasive device predicting cardiovascular health via pulse wave analysis.

ezCaretech Expands AI Native HIS Strategy Through New Partnership With Huinno

ezCaretech is transforming into an AI-powered healthcare platform, partnering with Huinno to enhance medical AI services and workflows.

Wontech Expands Surgical Device Business With $2.2 Million HOLINWON Supply Deals in Uzbekistan and Indonesia

Wontech expands into surgical devices, securing $2.2M contracts in Asia for its advanced holmium laser technology.

PharmaResearch Posts Near-40% Operating Margin as Rejuran and Medical Aesthetics Drive Growth

PharmaResearch reports a 39.2% operating profit margin, driven by strong sales in medical aesthetics and cosmetics, despite market competition.

Yonsei University Develops AI Platform for Early Autism Screening and Treatment

Yonsei University is developing an AI platform for autism screening, aiming for early detection and practical use in clinical settings.

Why 20 Years of Stem Cell Therapy Research Still Lacks Proven Results

Stem cell therapy shows promise but faces hurdles in clinical applications and approvals, with few successful treatments available.

Mastering U.S. Patent Risks: Essential Training for Korean Life Sciences Firms

The Korea Pharmaceutical and Bio-Pharma Association will host training on U.S. patent risks for local pharma and biotech professionals.

Mounjaro prescriptions surge 12-fold in 8 months, surpassing 200,000 monthly for the first time

Mounjaro prescriptions surged over tenfold in eight months, raising concerns about access for patients with obesity amid rising cosmetic demand.

YH35995: A Game-Changer for Gaucher Disease? FDA Grants Orphan Drug Designation

Yuhan Corp's YH35995 for Gaucher disease receives orphan drug designation, enhancing its development for rare diseases with unmet needs.

ST Pharm Secures Key mRNA-LNP Patent STP1244 in Japan

ST Pharm secures a patent in Japan for its mRNA delivery technology, enhancing its global market position and IP portfolio.

Revolutionary Male Contraceptive: New Method Halts Sperm Production Without Hormonal Side Effects

A Cornell team developed a reversible male contraceptive, blocking sperm production without hormonal side effects, using a compound called JQ1.

2026 Supplementary Budget: Support for Vulnerable Groups and Youth Jobs in an Era of High Inflation

South Korea's Health Ministry proposes a budget increase to support vulnerable groups, but faces criticism over its relevance and effectiveness.

Unlocking the Future of Cancer Treatment: UCI-101 CAR-NK Therapy by UCI Therapeutics

Matica BioLabs partners with UC Therapeutics to manufacture CAR-NK cell therapy, enhancing cancer treatment through dual-targeting technology.

Your Guide to Jaqbo: The New GERD Treatment Shaping the Future of Chronic Care

Onconic Therapeutics begins a Phase 3 trial for Jaqbo, aiming to expand GERD treatment options and enhance long-term management strategies.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.